CD4 and neoplasm: Furthermore, the association between cytotoxic CD4 T cells and response to anti-PDL1 therapy only held in patients with immune-inflamed tumors, not in immune excluded or desert tumors where the CD4 T cells would not be in contact with the tumor cells (131).